Respiratory muscle strength in ischemic cardiomyopathy and COVID-19 patients.

12 May 2024 (11:00 - 11:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Emilio Gutierrez Luna

Mexico (Mexico)

6 More presentations in this session

Presentation thumbnail

Risk of heart failure in type 1 diabetes compared with type 2 diabetes: insights from the UK Biobank

Doctor M. Vaduganathan (Boston, US)

Abstract Slides

Presentation thumbnail

Urinary albumin-to-creatinine ratio and progression of heart failure

Doctor A. Abdi (Tehran, IR)

Abstract Slides Video

Presentation thumbnail

Ultrasound-measured quadriceps thickness and mortality in older patients with heart failure

Doctor Y. Fujimoto (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF

Doctor M. Lassen (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Chronic heart failure - comorbidities 1

The Event

Event poster

Heart Failure 2024

12 May 2024 11:00 CET

You may be interested in

Congress Presentation

Exercise tolerance in post-SARS-COV-2 patients with ischemic cardiopathy

Congress Presentation

Body composition changes in patients with ischemic heart disease and postcovid-19 syndrome

Congress Presentation

Long COVID: insights from echocardiography, cardiac magnetic resonance, and endomyocardial Biopsies in previous healthy individuals with persistent chest pain

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources